Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | PPOX | P50336 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.32 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.32 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17164068 | 0.98 | PTGS1 (0.35) | PTGS1PTGS2PPOX | |
| SCHEMBL17164175 | 0.95 | PTGS1 (0.33) | PTGS1PTGS2PPOX | |
| SCHEMBL17164122 | 0.91 | — | — | |
| SCHEMBL17164192 | 0.77 | PTGS1 (0.35) | PTGS1PTGS2EPHX2APP | |
| SCHEMBL17164129 | 0.76 | PARP10 (0.44) | THRATHRBSCN9A | |
| SCHEMBL17164200 | 0.75 | PTGS1 (0.36) | PTGS1PTGS2 | |
| SCHEMBL17164202 | 0.74 | THRA (0.33) | PTGS1PTGS2THRATHRBPDGFRB | |
| SCHEMBL17164069 | 0.73 | PARP10 (0.42) | THRATHRBSCN9A | |
| SCHEMBL17164196 | 0.72 | PTGS1 (0.32) | PTGS1PTGS2PDGFRBPDGFRASCN9A | |
| SCHEMBL17164157 | 0.71 | PTGS1 (0.31) | PTGS1PTGS2THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10941122-B2 | Diaminotriazine derivatives as herbicides | BASF SE (DE) | 2021-03-09 | — | — | US | claimed |
| EP-3129359-B1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2021-03-03 | — | — | EP | claimed |
| EP-3129359-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | claimed |
| WO-2015155272-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | claimed |
| US-10941122-B2 | Diaminotriazine derivatives as herbicides | BASF SE (DE) | 2021-03-09 | — | — | US | disclosed |
| EP-3129359-B1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2021-03-03 | — | — | EP | disclosed |
| CN-106458937-A | Diaminotriazine derivatives as herbicides | 巴斯夫欧洲公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-3129359-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-02-15 | — | — | EP | disclosed |
| US-20170022170-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2017-01-26 | — | — | US | disclosed |
| WO-2015155272-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE (DE) | 2015-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10941122-B2 | Diaminotriazine derivatives as herbicides | DDT, CBR3, HDHD5 | PTGS1 3461/4885PTGS2 2532/4885PPOX 1265/4885 |
| US-20170022170-A1 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | DDT, CBR3, HDHD5 | PTGS1 3461/4885PTGS2 2532/4885PPOX 1265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.